Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 39
Titolo Data di pubblicazione Autore(i) File
Longitudinal follow up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogenic bone marrow transplant 1-gen-2007 Candoni, A.; Toffoletti, E.; Chiarvesioa, ; Michelutti, A.; Cavallin, M.; Damiani, Daniela; Fanin, R.
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 1-gen-2007 Candoni, A; Toffoletti, E; Chiarvesio, A; Michelutti, A; Cavallin, M; Damiani, D; Fanin, R.
Fludarabine-based induction therapy does not overcome the negative effect of bcrp (ABCG2) overexpression on remission duration in adult de novo acute myeloid leukemia patients 1-gen-2008 Tiribelli, Mario; Geromin, A; Michelutti, A; Cavallin, M; Candoni, A; Toffo letti, E; Chiarvesio, A; Fanin, R; Damiani, Daniela
T-cell chimerism and clinical outcome after reduced-intensity conditioning allogeneic stem cell transplantation 1-gen-2008 Toffoletti, Eleonora; Patriarca, Francesca; Chiarvesio, A.; Michelutti, A.; Sperotto, A.; Cavallin, M.; Battista, M. L.; Zaja, Francesco; Fanin, Renato
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 1-gen-2008 Tiribelli, Mario; Colatutto, A; Marin, L; Barbina, G; Qualizza, U; Damiani, Daniela; Toffoletti, Eleonora; Medeot, M; Candoni, A; Tonutti, E; Sala, P; Fanin, Renato
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 1-gen-2008 Candoni, A; Martinelli, G; Toffoletti, Eleonora; Chiarvesio, A; Tiribelli, Mario; Malagola, M; Piccaluga, Pp; Michelutti, A; Simeone, E; Damiani, Daniela; Russo, D; Fanin, Renato
No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy” 1-gen-2008 Toffoletti, Eleonora; Zaja, Francesco; Chiarvesio, A; Michelutti, A; Battista, M; Fanin, Renato
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 1-gen-2009 Toffoletti, Eleonora; Patriarca, Francesca; Cavallin, M.; Sperotto, A.; Battista, M. L.; Michelutti, A.; Medeot, M.; Damiani, Daniela; Fanin, Renato
MONITORING OF MINIMAL RESIDUAL DISEASE BY QUANTITATIVE WT1 GENE EXPRESSION AFTER REDUCED INTENSITY CONDITIONING ALLOGENEIC SCT IN ACUTE MYELOID LEUKEMIA 1-gen-2009 Candoni, A.; Toffoletti, E.; Cavallin, M.; Michelutti, A.; Damiani, Daniela; Fanin, R.
CONCOMITANT OVEREXPRESSION OF BCRP AND FLT3-ITD MUTATION ARE ASSOCIATED WITH POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS 1-gen-2009 Tiribelli, Mario; Damiani, Daniela; Geromin, A; Pianta, A; Fabbro, D; Michelutti, A; Cavallin, M; Toffoletti, E; Candoni, A; Cerno, M; Damante, Giuseppe; Fanin, Renato
MULTICENTER PROSPECTIVE CLINICAL TRIAL WITH LOW DOSE GEMTUZUMAB-OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN (GO-FLAI) AS INDUCTION THERAPY OF CD33-POSITIVE ACUTE MYELOID LEUKEMIA (AML) PATIENTS YOUNGER THAN 65 YEARS 1-gen-2009 2. 2. 8. Candoni, A.; Martinelli, G.; Gherlinzoni, F.; Papayanidis, C.; Toffoletti, E.; Simeone, E.; Ottaviani, E.; Gottardi, M.; Iacobucci, I.; Paolini, S.; Michelutti, A.; Lama, B.; Calistri, E.; Visani, G.; Isidori, A.; Piccaluga, P. P.; Damiani, Daniela; Russo, D; Baccarani, M.; Fanin, R.
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 1-gen-2009 Sperotto, A.; Patriarca, Francesca; Zaja, Francesco; Geromin, A.; Cerno, M.; Battista, M.; Medeot, M.; Toffoletti, E.; Damiani, Daniela; Fanin, R.
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 1-gen-2009 Geromin, A.; Cerno, M.; Miotti, V.; 1 Dreossi, C.; Cavallin, M.; Michelutti, A.; Toffoletti, E.; Fanin, R.; Damiani, Daniela
OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANT FOR REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA 1-gen-2009 Geromin, A.; Sperotto, A.; Patriarca, Francesca; Cerno, M.; Candoni, A.; Toffoletti, E.; Battista, M.; Medeot, M.; Damiani, Daniela; Fanin, R.
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. 1-gen-2009 Candoni, A.; Tiribelli, Mario; Toffoletti, E.; Cilloni, D.; Chiarvesio, A.; Michelutti, A.; Simeone, E.; Pipan, C.; Saglio, G.; Fanin, R.
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 1-gen-2009 Tiribelli, Mario; Geromin, A.; Michelutti, A.; Cavallin, M.; Candoni, A.; Toffoletti, E.; Fanin, R.; Damiani, Daniela
Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complication after allogeneic transplantation 1-gen-2009 Patriarca, Francesca; Poletti, V; Costabel, U; Battista, Ml; Sperotto, A; Medeot, M; Toffoletti, Eleonora; Fanin, Renato
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 1-gen-2010 Tiribelli, Mario; Damiani, Daniela; Geromin, A.; Michelutti, 1 A.; Cavallin, 1 M.; Pianta, 1 A.; Fabbro, 2 D.; Candoni, 2 A.; Toffoletti, 1 E.; Cerno, 1 M.; Marin, 1 L.; Damante, Giuseppe; Fanin, Renato
QUANTITATIVE ANALYSIS OF MN1 GENE EXPRESSION FOR EVALUATION OF MINIMAL RESIDUAL DISEASE IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA PATIENTS 1-gen-2010 Tiribelli, Mario; Toffoletti, E.; Gallina, R.; Damiani, Daniela; Candoni, A.; Fanin, R.
Monitoring of minimal residual disease by quantitative WT1 gene expression following reduce intensity conditioning allogenic stem cell transplantation in acute myeloid leukaemia 1-gen-2011 Candoni, A; Toffoletti, Eleonora; Gallina, R; Simeone, E.; Chiozzotto, M; Volpetti, S; Fanin, Renato
Mostrati risultati da 1 a 20 di 39
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile